SyntheticGestalt株式会社

SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.

SyntheticGestalt株式会社 is a company in medical engineering & biotechnology based in Tokyo, Japan, founded in 2018.

Profile

"SyntheticGestalt is a deeptech company focused on advancing the automation of inventions through artificial intelligence. Specializing in the discovery of new drug candidates and enzyme proteins, SyntheticGestalt develops autonomous systems to facilitate this process. By harnessing the synergy between biotechnology and AI, the company aims to accelerate the next industrial revolution. Utilizing proprietary machine learning models, SyntheticGestalt conducts exploration for new drug candidate compounds against drug targets. Collaborations with leading entities like Shionogi & Co. and Hokkaido University have also led to the identification of potential new drug candidates for anti-coronavirus treatments. The mission of SyntheticGestalt is to mass-produce valuable discoveries through autonomous systems, contributing to the advancement of civilization. By leveraging the power of artificial intelligence, the company strives to accelerate the evolution of civilization by mass-producing inventions."

As a business in medical engineering & biotechnology, SyntheticGestalt株式会社 is listed here with the public details available about it.

Tokyo, Japan is where the company is located.

Its current recorded stage is J-Startup selected company.

Its team size is recorded as 11-50 employees.

Website: syntheticgestalt.com